Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
Immune checkpoint blockade (ICB) therapy has transformed cancer treatment, but many tumors remain resistant. A new study from ...
Morning Overview on MSN
A cancer vaccine is still holding melanoma at bay five years into a trial
Patients with high-risk melanoma who received a personalized mRNA cancer vaccine alongside pembrolizumab continue to show ...
William Shatner and his daughter Melanie have revealed how they supported each other through simultaneous stage 4 cancer ...
Researchers have identified that local complement C3 expression in tumors prevents the accumulation of immunosuppressive ...
Subcutaneous checkpoint inhibitors drove up volume and forced staffing changes, according to Angie Maynard, PharmD, MS, and ...
Leveraging BostonGene’s AI Models to Optimize Patient Selection and Clinical DevelopmentTOKYO & WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, the developer of the leading AI model for tumor and immune ...
Atropos Health, the world’s largest creator of real-world evidence (RWE) for clinical decision making, today announced that it has contributed to 12 new studies in the first six months of 2026, ...
A multidisciplinary group of experts has issued recommendations for managing systemic cancer therapies in patients undergoing ...
Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the Oxford-based cancer immunotherapy developer listed on London's ...
TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results